| |SEPTEMBER 20266VIVID OUTLOOKC ONT E NT SHow Biologics and Complex Therapies Are Reshaping CDMO StrategyHow Can India Pharma Bridge the Gap Between Innovation and AccessHow Can Indian Pharma Strengthen Quality Amid Rising FDA ScrutinyAkhil Ravi,CEO, Aurigene Pharmaceutical Services LimitedAurelien Breton,Managing Director,Servier IndiaDr. Birendra Singh,Global Chief Quality Officer, Mankind PharmaAFTERWORDTHOUGHT CENTRAL24123438India's Hospitals Risk Falling into the U.S.-Style Fee-for-Service TrapViren Shetty,Executive Vice Chairman, Narayana Health 15 Pharma Marketing KPIs Indian Companies Should Track in 2026Why India's Pharma Manufacturing Boom Needs More Women in Core Plant Operations1030ANALYSIS0809TOP STORIES
< Page 5 | Page 7 >